Recent overviews of the literature revealed that SIRT4, although first described as a metabolic tumor suppressor [37], may display both tumor suppressor and oncogenic/cancer promoting activities, depending on the tumor type and checkpoint activating conditions [79,80]. The gene discussed is SIRT4; the disease is neoplasm.